Oncofactor

About:

Oncofactor develops cancer therapeutics that disrupt signaling pathways between tumors and the immune system.

Top Investors: ARCH Venture Partners, Alexandria Real Estate Equities, Amgen Ventures, Accelerator Corp., Washington Research Foundation

Description:

Oncofactor is a Seattle, Washington-based developer of cancer therapeutics that disrupt signaling pathways between tumors and the immune system.

Total Funding Amount:

$3.1M

Headquarters Location:

Seattle, Washington, United States

Founded Date:

2011-01-01

Founders:

Sarah Warren

Number of Employees:

1-10

Last Funding Date:

2013-08-30

IPO Status:

Private

Industries: